Condensed Statements of Shareholders' Deficiency (Unaudited) - USD ($)	3 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	$ (1,035,129)	$ (931,279)
Net loss	(24,713)	(22,742)
Ending balance	$ (1,059,842)	$ (954,021)
Common Stock
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance (in shares)	1,899,575	1,899,575
Beginning balance	$ 1,900	$ 1,900
Ending balance (in shares)	1,899,575	1,899,575
Ending balance	$ 1,900	$ 1,900
Additional Paid-in Capital
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	8,418,684	8,418,684
Ending balance	8,418,684	8,418,684
Accumulated Deficit
Increase (Decrease) in Shareholders' Equity [Roll Forward]
Beginning balance	(9,455,713)	(9,351,863)
Net loss	(24,713)	(22,742)
Ending balance	$ (9,480,426)	$ (9,374,605)